Particle Sciences, Inc. (PSI) is a leading CRO to the pharmaceutical, biotech, and drug device industries. Building on decades of experience, PSI offers expertise in nano-based approaches to drug delivery and brings this skill-set to bear on its clients’ goals, independent of the dosage form, from topical to ocular to intravenous to intrathecal. Through internal development and an active in-licensing program, the company has a broad array of technologies from which to choose. This approach has resulted in an average annualized growth rate of over 25% and a very high rate of new project awards from existing clients. As Vice President of Drug Development, Dr. Robert W. Lee is responsible for overseeing PSI’s scientific direction. Drug Delivery Technology recently interviewed Dr. Lee to discuss how his company is managing to thrive in such a tough business environment.